Lipoprotein storage disorders manifest as a heterogeneous group of genetic metabolic diseases. These conditions are characterized by the accumulation of abnormal lipoproteins, primarily within the tissues, leading to a spectrum of clinical manifestations. The underlying mechanisms involve defects in the processing of apolipoproteins or enzymes invo